Celcuity Inc.
Celcuity Inc. (CELC) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CELC · as of Jun 8, 2026
Key Statistics
Explore Celcuity Inc. Data
celc stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 12 · Buy rate: 100.0%
The CELC analyst consensus is Buy, based on ratings from 12 Wall Street analysts over the past 3 months. The average 12-month price target is $153.22, representing +73.56% upside from the current price of $88.28.
Competitors & Peers
celc competitorsCELC
AAPG
APGE
CGON
CNTA
IRONStock Performance
Full HistoryAbout Celcuity Inc.
Celcuity Inc. a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platfor…
what is celcuity inc. · celc stock overview · celcuity inc. company profile · who is celcuity inc. ceo · celc NASDAQ · celcuity inc. headquarters · celcuity inc. business segments
About Stock Overview & Key Data
Celcuity Inc. (CELC) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Sep 20, 2017. As of the latest trading session, CELC stock price is $88.28, with a market capitalization of $4.3B. The stock has returned +583.81% over the past 12 months and -11.49% year-to-date.
According to 12 Wall Street analysts, the consensus rating for Celcuity Inc. stock is Buy, with an average 12-month price target of $153.22. In fiscal year 2025, Celcuity Inc. reported revenue of — and net income of -$177.0M. For detailed data — including Celcuity Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Celcuity Inc. (CELC) stock price is $88.28. The stock is traded on NASDAQ under the ticker symbol CELC. The 52-week range is $11.28 – $151.02.